More recently, such principles have also been applied to the Ph-like B-ALL subtype, which comprises 15–20% high-risk pediatric ALL cases and is characterized by a gene expression profile very similar to that of Ph+ ALL despite the lack of BCR::ABL1 fusion. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.